Vicoprofen is a combination medication indicated for the short-term management of acute pain that is severe enough to require an opioid analgesic, and for which alternative treatments are inadequate. The drug is prescribed to provide relief from pain associated with several common clinical scenarios, including discomfort following dental procedures or minor surgery.

It is also used for the symptomatic relief of musculoskeletal pain resulting from injury or strain, as well as severe, acute forms of menstrual discomfort. The medication's primary function is the temporary reduction of pain intensity, which may support an individual's improved functional status while recovering from a painful condition. This approach aims to allow individuals to resume certain daily activities sooner than they might otherwise.

Quick Fact: Relief for Moderate to Severe Acute Pain

Who Can and Cannot Use Vicoprofen? (Official Regulatory Information)

Vicoprofen (Hydrocodone Bitartrate and Ibuprofen) eligibility is strictly defined by regulatory documents, focusing on hypersensitivity, specific clinical conditions, and age.

Absolute Contraindications (Who Must Not Use):

Condition/Population	Restriction
Hypersensitivity	Known allergy to hydrocodone or ibuprofen, or allergic reactions (e.g., asthma, hives) to aspirin or other NSAIDs.
Surgical	Treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Respiratory	Patients with acute or severe bronchial asthma or significant respiratory depression.
Gastrointestinal	Known or suspected gastrointestinal obstruction, including paralytic ileus.

---

Age and Specific Population Restrictions:

• Age: Use is established for adults and adolescents ge 16 years of age. Safety and efficacy are not established in children younger than 16 years.
• Pregnancy: Avoid use starting at 20 weeks or later in pregnancy due to risk of fetal harm.
• Organ Impairment: Use with caution in patients with severe hepatic or renal impairment; use in advanced renal disease should be avoided.

This information reflects mandatory boundaries for use as dictated by regulatory authorities.

The official interaction profile for Vicoprofen, a fixed-dose combination of an opioid (hydrocodone) and an NSAID (ibuprofen), is defined by distinct pharmacokinetic and pharmacodynamic constraints established in government regulatory documentation.

Prohibited Combinations and Timing Rules

The use of this product is strictly contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery due to risks linked to the NSAID component. Concurrent use with other NSAIDs is also prohibited. Furthermore, a mandatory timing rule applies to Monoamine Oxidase Inhibitors (MAOIs), which must not be taken within 14 days of starting or stopping this product.

Pharmacokinetic and Pharmacodynamic Risks

Co-administration with CYP450 3A4 inhibitors may result in an increase in hydrocodone plasma concentrations, which is an exposure-modifying interaction. Similarly, discontinuing a CYP450 3A4 inducer may also increase hydrocodone levels. The most significant pharmacodynamic interaction involves CNS Depressants (including alcohol), which may result in profound sedation and respiratory depression. A risk of Serotonin Syndrome is documented with co-administration of Serotonergic Drugs.

Substance-Specific and Population Notes

The regulatory profile notes that Elderly Patients are at a greater risk for serious gastrointestinal adverse events. Interactions are also documented with substances like Grapefruit Juice and St. John's Wort.

Co-Inhibition of Opioid Receptors and Cyclooxygenase Enzymes

Vicoprofen acts through both central neural and peripheral enzymatic pathways to influence nociceptive signal processing across two distinct physiological levels. This dual approach engages mechanisms that regulate overactive signaling by acting on two distinct biochemical targets.

---

Modulating Central mu-Opioid Receptor Signaling

The hydrocodone component acts as a mu-opioid receptor agonist within the central nervous system. This action initiates a G-protein-coupled signaling cascade that alters the efficiency of nociceptive signal propagation through neural pathways, influencing downstream pathway activity that regulates signal conductance.

---

Inhibiting Prostaglandin Synthesis via COX Enzymes

The ibuprofen component is a non-selective cyclooxygenase (COX) enzyme inhibitor, which blocks the conversion of arachidonic acid into prostaglandins. These prostanoids are chemical signals involved in peripheral nociceptor sensitization. By modifying this early molecular step, the drug consequently reduces the concentration of pain-sensitizing prostaglandins at the local site.

Vicoprofen is an oral tablet containing the fixed combination of hydrocodone bitartrate (7.5 mg) and ibuprofen (200 mg) for pain management. Adherence to administration instructions is essential for proper administration.

Administration and Dosing

The route of administration is oral. The tablet must be swallowed whole and should not be crushed, broken, or chewed. The recommended dose for adults is one tablet (7.5 mg hydrocodone/200 mg ibuprofen) taken as needed for pain. This dose may be repeated every 4 to 6 hours.

Dosing Parameter	Instruction (Adults)
Single Dose	One tablet
Frequency	Every 4 to 6 hours, as needed (PRN)
Maximum Daily Limit	Not to exceed five tablets in 24 hours

Use Constraints and Duration

Treatment is indicated for the short-term management of acute pain. Use is generally restricted to a duration of less than 10 days. The guiding principle is to use the lowest effective dosage for the shortest duration possible consistent with treatment goals. For elderly patients, the general caution is to use the lowest effective dose.

Research Evidence / Overview of Studies for Vicoprofen

---

Evidence for Short-Term Acute Pain Management

Vicoprofen (Hydrocodone Bitartrate and Ibuprofen) was studied for the management of pain that is acute and severe enough to potentially require an opioid. The main research evidence was evaluated in short-term, controlled studies known as Randomized Controlled Trials (RCTs) and subsequent meta-analyses. These studies research examined how symptoms change over time in adult patients often experiencing acute discomfort following procedures like dental extractions or minor surgery.

In these research settings, studies monitored patient-reported outcomes describing perceived discomfort. Trials compared the combination to either an inactive pill (placebo) or to the individual components of the drug taken separately. Findings describe patterns observed in the studies over defined time intervals, and research highlights changes measured during the study period related to physical discomfort, which contributes to the broader evidence landscape regarding short-term symptom patterns.

---

Long-Term Studies and Follow-Up Data

Because Vicoprofen was evaluated in conditions involving periods of heightened symptoms that are typically short-lived, the available evidence is primarily focused on short-term changes. The follow-up durations were limited in the primary clinical trials, meaning that long-term effects are not fully established.

There is limited information for long-term outcomes that reflect daily-life functioning or activity level beyond the initial few days of treatment. Research does not fully characterize how reported outcomes describing episodic or acute changes persist or evolve after the treatment period ends.

---

What Remains Unclear or Unstudied About Vicoprofen

Data for certain groups remain insufficient. For instance, few data are available for older adults, and there is limited information on how the reported patterns observed in studies might apply to pediatric patients (children). Additionally, comparative evidence is lacking for many direct comparisons against all currently available alternative combination analgesics. The available research structure provides context but not individual predictions about a patient’s experience.

Common questions about Vicoprofen (FAQ)

Q: How quickly does Vicoprofen start working for pain?

Studies examining the drug’s processing in the body indicate that the active ingredients generally reach their peak concentration in the blood within approximately two hours after the tablet is taken orally. This timeline reflects the period when peak concentrations of the active ingredients are generally observed in the body.

Q: How long do the effects of Vicoprofen usually last?

Official dosing guidelines document an administration interval of every four to six hours as needed for pain. This interval reflects the expected duration of the pain relief effect based on the elimination half-life of the opioid component.

Q: Are there common stomach side effects with Vicoprofen?

Official product information lists several common gastrointestinal side effects (occurring in 1% to <10% of patients). These include nausea and constipation. Uncommon reactions can involve dyspepsia (indigestion), diarrhea, and vomiting.

Q: What are some serious side effects linked to Vicoprofen?

Regulatory warnings highlight the potential for serious adverse reactions related to both components. These risks include life-threatening respiratory depression from the opioid, and serious gastrointestinal bleeding or perforation and cardiovascular thrombotic events (like heart attack or stroke) from the NSAID component.

Q: Can Vicoprofen interact with over-the-counter cold medicines?

The official label strictly prohibits taking Vicoprofen with other nonsteroidal anti-inflammatory drugs (NSAIDs), which are common ingredients in many over-the-counter cold and pain remedies. Because of this risk, a review by a healthcare professional is necessary to determine if an over-the-counter cold medicine contains an interacting substance.

Q: Is it safe to take Tylenol (acetaminophen) at the same time as Vicoprofen?

Official Vicoprofen labeling prohibits concurrent use with other NSAIDs, but it does not explicitly list acetaminophen (Tylenol) as a prohibited combination. The complex nature of drug interactions means that any plan to combine pain relievers should be reviewed by a healthcare professional.

Q: Can people with high blood pressure use Vicoprofen?

Official warnings state that the NSAID component carries risks related to cardiovascular events. Patients with pre-existing conditions like hypertension (high blood pressure) are noted in regulatory information as being at potentially greater risk and requiring professional oversight.

Q: Does Vicoprofen interact with antidepressant medications?

Yes, official documents warn that combining Vicoprofen with serotonergic drugs, a category that includes many antidepressants, carries a documented risk. This interaction can potentially lead to a serious condition called Serotonin Syndrome.

Q: Why is grapefruit juice sometimes mentioned with pain medications like Vicoprofen?

Regulatory documents list interactions with grapefruit juice because it can affect how the body breaks down the hydrocodone component. This effect involves inhibiting the CYP450 3A4 enzyme, which may lead to an increase in the hydrocodone concentration in the bloodstream.

Q: Can Vicoprofen affect driving or operating machinery?

Yes, regulatory information indicates that common side effects such as dizziness and somnolence (drowsiness) are possible. These documented effects should be considered before performing activities like driving or operating complex machinery.

Q: Is there a risk of dependence associated with Vicoprofen?

Vicoprofen is formally classified as a Schedule II controlled substance. This classification exists because the drug carries a documented risk of abuse, misuse, and the development of physical dependence.

Q: Can Vicoprofen be used for chronic pain conditions?

No. The official labeling for Vicoprofen strictly mandates that the drug is indicated only for the short-term management of acute pain. It is not intended or approved for treating long-term or chronic pain management.

Q: Is Vicoprofen habit-forming if used for a short time?

The drug is a Schedule II substance due to its risk of dependence. Regulatory documents state that use is restricted to the shortest duration possible, typically less than 10 days, to minimize potential risks, including dependence.

Q: Can Vicoprofen be taken by children or teenagers?

Official safety and effectiveness information is established only for adults and adolescents 16 years of age and older. Use in children younger than 16 years of age is not established in the regulatory documentation.

Q: What is the typical timeframe for stopping Vicoprofen use?

The treatment is generally restricted to a duration of less than 10 days for acute pain. Regulatory documents include a warning about abrupt discontinuation for patients who have developed physical dependence.

Q: Is Vicoprofen available in different strengths?

Vicoprofen is officially approved as a fixed-combination tablet. This single formulation contains hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg.

Q: Do official documents mention long-term safety data for Vicoprofen?

Official research is concentrated on short-term outcomes because the drug is prescribed for acute pain. Regulatory documents describe that long-term effects are not fully established due to the limited duration of follow-up in the primary clinical trials.

Q: Is it normal to feel dizzy or lightheaded after taking Vicoprofen?

Yes, official documentation confirms that dizziness is a common side effect, which was reported to occur in 1% to <10% of patients during clinical trials. Feeling lightheaded falls under this expected side effect.

Q: What is the mechanism by which Vicoprofen helps with fever?

The ibuprofen component is an NSAID that contributes to fever reduction. It does this by inhibiting cyclooxygenase (COX) enzymes, which blocks the production of prostaglandins, chemical signals that are involved in the body's fever response.

Q: Are there warnings about combining Vicoprofen with muscle relaxers?

Yes, regulatory warnings are documented for combining the drug with Central Nervous System (CNS) depressants, a class that includes muscle relaxers. This combination carries a significant risk of profound sedation and serious respiratory depression.

Q: Can Vicoprofen be crushed or split?

The official administration instructions state the tablet must be swallowed whole. It is explicitly stated in regulatory information that the tablet should not be crushed, broken, or chewed.

Q: Does Vicoprofen work for dental pain?

Official research evidence for the drug's use was collected in studies that examined its effect on acute discomfort following procedures like dental extractions. The drug is indicated for moderate to severe acute pain.

Q: Can Vicoprofen cause changes in mood or confusion?

Regulatory documents list anxiety as an uncommon side effect. Warnings about interactions with serotonergic drugs also note the potential for mental status changes and agitation.

Vicoprofen (hydrocodone bitartrate and ibuprofen tablets) must be stored and disposed of according to strict regulatory guidelines, primarily due to the hydrocodone component.

Storage Requirements

Vicoprofen must be stored in a closed container at controlled room temperature and kept away from moisture, direct light, and excessive heat. It is critical that the medicine not be frozen.

Mandatory security requires the tablets be kept securely out of sight and reach of children and in a location not accessible by others, as accidental ingestion can be fatal.

Disposal Instructions

Unused or expired Vicoprofen must be disposed of promptly. The preferred method is to drop off unused opioid medication at an authorized drug take-back location.

If a take-back program is unavailable, official guidance advises that unused medication may be flushed down the toilet to prevent accidental ingestion.